Skip to main content

Table 1 Patients with head and neck cancer treated with cisplatin. KPS Karnofsky performance status, SD standard deviation

From: MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancer

Patient and clinical characteristics
  Patients whose miRNA samples were sequenced All patients (n = 60)
Non-nephrotoxicity group (n = 6) Nephrotoxicity group (n = 6)
Age (mean ± SD, years) 60.3 ± 4.9 57.5 ± 7.4 58.4 ± 7.3
Gender (n, %)
 Men 5 (83.3) 4 (66.7) 54 (90.0)
 Women 1 (16.7) 2 (33.3) 6 (10.0)
Ethnicity (n, %)
 Caucasian 4 (66.7) 6 (100.0) 45 (75.0)
 Non-Caucasian 2 (33.3) 0 (0.0) 15 (25.0)
Smoking category (n, %)
 Never smoked 1 (16.7) 1 (16.7) 6 (10.0)
 Light smoker 0 (0.0) 0 (0.0) 3 (5.0)
 Moderate smoker 0 (0.0) 1 (16.7) 4 (6.7)
 Heavy smoker 5 (100.0) 4 (66.6) 47 (78.3)
Drinking category (n, %)
 Abstainer 2 (33.3) 2 (33.3) 9 (15.0)
 Light drinker 0 (0.0) 0 (0.0) 5 (8.3)
 Moderate drinker 0 (0.0) 0 (0.0) 2 (3.3)
 Heavy drinker 3 (50.0) 1 (16.7) 16 (26.7)
 Very heavy drinker 1 (16.7) 3 (50.0) 28 (46.7)
KPS (n, %)
 60 0 (0.0) 0 (0.0) 1 (1.7)
 70 0 (0.0) 0 (0.0) 1 (1.7)
 80 2 (33.3) 3 (50.0) 9 (15.0)
 90 4 (66.7) 3 (50.0) 40 (66.6)
 100 0 (0.0) 0 (0.0) 9 (15.0)
Tumor site (n, %)
 Oropharynx 0 (0.0) 1 (16.7) 15 (25.0)
 Hypopharynx 2 (33.3) 3 (50.0) 9 (15.0)
 Larynx 1 (16.7) 1 (16.7) 13 (21.7)
 Oral cavity 3 (50.0) 1 (16.7) 20 (33.3)
 Hypopharynx + Larynx 0 (0.0) 0 (0.0) 1 (1.7)
 na 0 (0.0) 0 (0.0) 2 (3.3)
Stage (n, %)
 I 0 (0.0) 0 (0.0) 0 (0.0)
 II 0 (0.0) 0 (0.0) 6 (10.0)
 III 1 (16.7) 0 (0.0) 7 (11.6)
 IV 5 (83.3) 6 (100.0) 46 (76.7)
 na 0 (0.0) 0 (0.0) 1 (1.7)
Nephrotoxicity parameters
Serum creatinine, SCr (mg/dL)
  Baseline 0.94 ± 0.18 0.75 ± 0.10 0.82 ± 0.20
  D5 0.94 ± 0.21 3.39 ± 2.13 1.36 ± 1.01
Creatinine clearance (mL/min)
  Baseline 70.20 ± 22.93 97.62 ± 40.55 87.70 ± 26.90
  D5 69.72 ± 24.01 25.05 ± 11.46 61.86 ± 25.54
Blood urea nitrogen, BUN (mg/dL)
  Baseline 38.50 ± 14.28 21.33 ± 9.48 28.75 ± 10.95
  D5 45.67 ± 14.88 92.00 ± 40.61 53.63 ± 22.99